
SCIENCE COMMERCIALISATION
What will break your deep tech commercialisation?
The technology shows promise. But is there a viable route to market for it? What should be done next and who contributes how? I stress-test the commercial case and show you what’s supported, what’s missing and how to cut through noise.
Where do you need a second pair of eyes?
Is this worth a closer look? → First assessment
Where could our plan break? → Second opinion or red team
What should happen first? → Commercial strategy or programme design
The buyer is interested. Why aren’t they moving?
A buyer likes the technology but won’t act on lab data alone. Before paying for another test, the transfer team asks what result, under which operating conditions, would let the buyer move forward.
THE CHECK
Would this happen without your support?
If the team could reach the same buyer on its own, look for the obstacle your organisation is better placed to remove.
Start by asking who can act on the evidence, and what they would do next.

BEFORE
A promising technology.
An unclear next step.
Several routes look plausible. Which one could a buyer or delivery partner actually act on?
AFTER THE WORK
A clearer next step,
with conditions.
A condition to test, a stakeholder who can help, and a signal for whether to continue.
What should you test before you scale?

Who you’ll work with
Hi, I'm Maria Ksenia Witte
You work directly with me: a scientist and independent commercialisation expert. I will challenge the assumptions, explain my judgement and tell you what would change it. You get a clear position — and the evidence to defend your next move.
250+ cases assessed · 25+ programmes & ecosystems
€120M+ allocation exposure
My QUATISE® methodology is built on formally certified applied RD&I under OECD Frascati criteria (validated through the German Federal Ministry of Research, Technology and Space).

























